Product Information
DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.6867 per EA under NDC 42571013360. Its NADAC has been published 237 times since Feb 9, 2022.
FDA first approved this application on Jul 15, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 200 mg/1; ug/1
Manufacturer
Micro Labs LimitedNDC
42571013360
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DICLOFENAC SODIUM; MISOPROSTOLApproval Type
Generic (ANDA)
FDA Application
ANDA204355FDA Approved
7/15/2021
TE Code
AB
On Market Since
9/1/2021
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has been published 237 times since Feb 9, 2022, and over the history we have for it it has declined 51.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6867 per EA |
|---|---|
| All-time high | $1.5755 (Apr 10, 2024) |
| All-time low | $0.6867 (Aug 19, 2026) |
| 52-week high | $1.0044 |
| 52-week low | $0.6867 |
| Median price | $0.9949 |
| Average price | $1.0526 |
| Largest weekly change | +59.0% (Mar 20, 2024) |
| Weeks tracked | 237 |
| Tracking since | Feb 9, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diclofenac Sodium/Misoprostol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET, manufactured by Micro Labs Limited, is $0.6867 per EA (NDC 42571013360), effective Aug 19, 2026.
How has the price of DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has declined 51.9%. It has been tracked across 237 weekly CMS publications since Feb 9, 2022.
What are the highest and lowest recorded NADAC prices for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
Since Feb 9, 2022, the NADAC for DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET has ranged from a low of $0.6867 (Aug 19, 2026) to a high of $1.5755 (Apr 10, 2024), with a median of $0.9949 per EA.
Are there cheaper alternatives to DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET?
DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET (NDC 42571013360) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.